Profile data is unavailable for this security.
About the company
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.
- Revenue in USD (TTM)25.19m
- Net income in USD-34.53m
- Incorporated2013
- Employees144.00
- LocationZomedica Corp100 Phoenix Drive, Suite 125ANN ARBOR 48108United StatesUSA
- Phone+1 (734) 369-2555
- Fax+1 (780) 440-1377
- Websitehttps://zomedica.com/
Mergers & acquisitions
| Acquired company | ZOM:ASQ since announced | Transaction value |
|---|---|---|
| Qorvo Biotechnologies LLC | -9.25% | -- |
| Structured Monitoring Products Inc | -30.86% | 18.00m |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 48.53m | 4.95% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 10.39m | 1.06% |
| Geode Capital Management LLCas of 31 Dec 2023 | 10.12m | 1.03% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 3.32m | 0.34% |
| ProShare Advisors LLCas of 31 Dec 2023 | 2.57m | 0.26% |
| Brown Brothers Harriman & Co. (Investment Management)as of 31 Dec 2023 | 2.47m | 0.25% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 1.80m | 0.18% |
| Citadel Securities LLCas of 31 Dec 2023 | 816.60k | 0.08% |
| T. Rowe Price International Ltd.as of 31 Dec 2023 | 672.20k | 0.07% |
| Two Sigma Securities LLCas of 31 Dec 2023 | 420.95k | 0.04% |
